Peptide Stability and Degradation: Temperature, Light, Oxidation and Aggregation
The short answer
Peptides can change over time through chemical reactions and physical processes. Important pathways include oxidation, deamidation, hydrolysis or bond cleavage, isomerization and aggregation. Temperature, light, oxygen, moisture, pH, concentration, surfaces and formulation conditions can influence these changes.
No single storage statement or purity number proves that a peptide remained unchanged. Stability is established for a defined material, container, condition and time using stability-indicating analytical methods.
Chemical and physical stability
Chemical degradation changes covalent structure. Oxidation can affect susceptible amino-acid side chains. Deamidation and isomerization can alter asparagine- or aspartate-containing regions. Hydrolysis can cleave peptide bonds.
Physical instability changes higher-order association or appearance without necessarily beginning with a new covalent structure. Aggregation, adsorption to surfaces and precipitation are examples. Chemical and physical pathways can interact: oxidation may promote aggregation, while aggregation can complicate chemical analysis.
Temperature and time
Higher temperature often accelerates chemical reactions and molecular motion, but the relationship is material- and condition-specific. Accelerated studies can help identify degradation pathways; they do not automatically establish an exact long-term shelf life under every condition.
Freeze–thaw stress may also affect some peptide or protein systems through concentration changes, interfaces or phase separation. Findings must come from the exact material and container system rather than a general assumption about all peptides.
Light, oxygen and moisture
Light can contribute to photochemical reactions in susceptible molecules or formulations. Oxygen can drive oxidation, and trace metals or peroxides may influence reaction rates. In solid materials, residual moisture and local molecular mobility can affect degradation even when the material appears dry.
The practical importance of each factor depends on sequence, formulation, packaging and analytical sensitivity.
pH and molecular environment
Solution pH can shift the balance among degradation pathways. A published exenatide study, for example, observed different dominant pathways across pH conditions, including oxidation, deamidation and aggregation. That result illustrates the importance of environment; it is not a universal recipe for other peptides.
Concentration, ionic strength and contact surfaces can also influence self-association and adsorption. Comparisons are meaningful only when experimental conditions are reported clearly.
What analytical testing can show
High-performance liquid chromatography can separate a main peak from some related substances. Mass spectrometry can support identity and detect certain mass changes. Size-exclusion chromatography and light-scattering methods can investigate aggregation. Spectroscopic and electrophoretic methods may provide complementary information.
Each method has limits. A purity result from one chromatographic method does not necessarily reveal every aggregate, isomer, sequence variant, counter-ion, residual solvent or microbial concern. Orthogonal methods answer different questions.
Stability-indicating evidence
A stability-indicating method can distinguish the material of interest from relevant degradation products under the conditions studied. A credible stability program specifies lots, containers, temperatures, humidity where relevant, time points, acceptance criteria and analytical methods.
A certificate of analysis is usually a batch snapshot. Unless it includes validated stability data, it should not be interpreted as proving performance throughout an unstated period or after untested handling.
Key points
- Chemical degradation and physical instability are different but can interact.
- Temperature, light, oxygen, moisture, pH and surfaces can matter.
- Stability conclusions apply to defined materials and conditions.
- One purity percentage cannot characterize every degradation pathway.
- Orthogonal, stability-indicating methods provide stronger evidence than a single test.
What this article does not establish
This article does not provide reconstitution, preparation or administration instructions and does not establish the stability, shelf life, sterility, safety or suitability for human use of any AURAPEP product.
References
- Lai MC, Topp EM. Solid-state chemical stability of proteins and peptides. J Pharm Sci. 1999. https://pubmed.ncbi.nlm.nih.gov/10229638/
- Manning MC, Patel K, Borchardt RT. Stability of protein pharmaceuticals. Pharm Res. 1989. https://pubmed.ncbi.nlm.nih.gov/2687836/
- Jenkins N. Post-translational modifications of recombinant proteins: significance for biopharmaceuticals. Mol Biotechnol. 2008. https://pubmed.ncbi.nlm.nih.gov/18327554/
- Benet A, et al. The Effects of pH and Excipients on Exenatide Stability in Solution. Pharmaceutics. 2021. https://pubmed.ncbi.nlm.nih.gov/34452224/
- Caputo N, et al. Mechanisms of glucagon degradation at alkaline pH. Peptides. 2013. https://pubmed.ncbi.nlm.nih.gov/23651991/